This is important: Goldman Sachs ask who is financing medical innovation and what should be financed for best returns. They do not say the FDA is bad for busine

This is important: Goldman Sachs ask who is financing medical innovation and what should be financed for best returns. They do not say the FDA is bad for business, it's the medical field itself that has problems delivering returns.